KORU Medical Systems, Inc. Announces 2024 Annual Meeting of Shareholders
Ticker: KRMD · Form: DEF 14A · Filed: Mar 28, 2024 · CIK: 704440
| Field | Detail |
|---|---|
| Company | Koru Medical Systems, Inc. (KRMD) |
| Form Type | DEF 14A |
| Filed Date | Mar 28, 2024 |
| Risk Level | |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: Proxy Statement, Annual Meeting, Shareholder Vote, Executive Compensation, Equity Incentive Plan
TL;DR
<b>KORU Medical Systems, Inc. schedules its 2024 Annual Shareholder Meeting for May 9th, with key votes on director elections, executive compensation, and equity incentive plans.</b>
AI Summary
KORU Medical Systems, Inc. (KRMD) filed a Proxy Statement (DEF 14A) with the SEC on March 28, 2024. KORU Medical Systems, Inc. will hold its 2024 Annual Meeting of Shareholders on May 9, 2024, at 8:00 a.m. Eastern Time. The meeting will take place at the Company's offices located at 100 Corporate Drive, Mahwah, NJ 07495. Shareholders will vote on the election of directors and the advisory approval of executive officer compensation. Key agenda items include the ratification of independent registered public accountants and the approval of the 2024 Omnibus Equity Incentive Plan. Shareholders of record as of March 11, 2024, are entitled to notice and voting rights for the meeting.
Why It Matters
For investors and stakeholders tracking KORU Medical Systems, Inc., this filing contains several important signals. This filing is a definitive proxy statement, indicating the company is formally seeking shareholder votes on critical governance and compensation matters. The agenda includes the election of directors and approval of the 2024 Omnibus Equity Incentive Plan, which directly impacts future executive and employee compensation and potential stock dilution.
Risk Assessment
Risk Level: — KORU Medical Systems, Inc. shows moderate risk based on this filing. The filing is a routine proxy statement for an annual meeting and does not contain new financial or operational information, thus posing minimal immediate risk.
Analyst Insight
Shareholders should review the proxy materials to understand the proposed director nominees, executive compensation details, and the implications of the 2024 Omnibus Equity Incentive Plan before the May 9th meeting.
Key Numbers
- May 9, 2024 — Annual Meeting Date (Date of the 2024 Annual Meeting of Shareholders.)
- 8:00 a.m. Eastern Time — Annual Meeting Time (Time of the 2024 Annual Meeting of Shareholders.)
- March 11, 2024 — Record Date (Shareholders of record on this date are entitled to vote.)
Key Players & Entities
- KORU Medical Systems, Inc. (company) — Registrant and filer of the proxy statement.
- May 9, 2024 (date) — Date of the 2024 Annual Meeting of Shareholders.
- March 11, 2024 (date) — Record date for determining shareholders entitled to notice and vote.
- 100 Corporate Drive, Mahwah, NJ 07495 (location) — Location of the Company's offices and the Annual Meeting.
- 2024 Omnibus Equity Incentive Plan (plan) — A key item for shareholder approval at the meeting.
FAQ
When did KORU Medical Systems, Inc. file this DEF 14A?
KORU Medical Systems, Inc. filed this Proxy Statement (DEF 14A) with the SEC on March 28, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by KORU Medical Systems, Inc. (KRMD).
Where can I read the original DEF 14A filing from KORU Medical Systems, Inc.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by KORU Medical Systems, Inc..
What are the key takeaways from KORU Medical Systems, Inc.'s DEF 14A?
KORU Medical Systems, Inc. filed this DEF 14A on March 28, 2024. Key takeaways: KORU Medical Systems, Inc. will hold its 2024 Annual Meeting of Shareholders on May 9, 2024, at 8:00 a.m. Eastern Time.. The meeting will take place at the Company's offices located at 100 Corporate Drive, Mahwah, NJ 07495.. Shareholders will vote on the election of directors and the advisory approval of executive officer compensation..
Is KORU Medical Systems, Inc. a risky investment based on this filing?
Based on this DEF 14A, KORU Medical Systems, Inc. presents a moderate-risk profile. The filing is a routine proxy statement for an annual meeting and does not contain new financial or operational information, thus posing minimal immediate risk.
What should investors do after reading KORU Medical Systems, Inc.'s DEF 14A?
Shareholders should review the proxy materials to understand the proposed director nominees, executive compensation details, and the implications of the 2024 Omnibus Equity Incentive Plan before the May 9th meeting. The overall sentiment from this filing is neutral.
How does KORU Medical Systems, Inc. compare to its industry peers?
KORU Medical Systems operates in the medical instruments and apparatus industry, focusing on surgical and medical devices.
Are there regulatory concerns for KORU Medical Systems, Inc.?
The filing is made under Section 14(a) of the Securities Exchange Act of 1934, which governs the solicitation of proxies from shareholders.
Risk Factors
- Proxy Statement Filing [low — regulatory]: The company is filing a definitive proxy statement (DEF 14A) to solicit shareholder votes for its annual meeting.
Industry Context
KORU Medical Systems operates in the medical instruments and apparatus industry, focusing on surgical and medical devices.
Regulatory Implications
The filing is made under Section 14(a) of the Securities Exchange Act of 1934, which governs the solicitation of proxies from shareholders.
What Investors Should Do
- Review the list of director nominees and their qualifications.
- Analyze the details of the executive compensation proposals.
- Understand the terms and potential impact of the 2024 Omnibus Equity Incentive Plan.
Key Dates
- 2024-05-09: Annual Meeting of Shareholders — Shareholders will vote on key corporate matters including director elections and compensation plans.
- 2024-03-11: Record Date — Determines which shareholders are eligible to vote at the Annual Meeting.
Glossary
- DEF 14A
- Definitive Proxy Statement (This form is filed with the SEC to provide shareholders with information about matters to be voted on at an annual or special meeting.)
- Omnibus Equity Incentive Plan
- A plan that allows a company to grant various types of equity-based compensation to employees and executives. (Shareholder approval is required for new equity incentive plans, which can impact dilution and future compensation costs.)
Year-Over-Year Comparison
This is the initial filing for the 2024 proxy season, providing details for the upcoming annual meeting.
Filing Stats: 4,707 words · 19 min read · ~16 pages · Grade level 12 · Accepted 2024-03-28 16:30:36
Key Financial Figures
- $0.01 — Company’s common stock, par value $0.01 per share (“shares” or &ldq
Filing Documents
- schedule_14a.htm (DEF 14A) — 461KB
- koru_logo.jpg (GRAPHIC) — 13KB
- proxy_card-1.jpg (GRAPHIC) — 407KB
- proxy_card-2.jpg (GRAPHIC) — 418KB
- proxy_chart-1.jpg (GRAPHIC) — 81KB
- proxy_chart-2.jpg (GRAPHIC) — 80KB
- proxy_internet.jpg (GRAPHIC) — 1KB
- proxy_mail.jpg (GRAPHIC) — 1KB
- proxy_mobile.jpg (GRAPHIC) — 1KB
- proxy_qr-code.jpg (GRAPHIC) — 9KB
- proxy_signature.jpg (GRAPHIC) — 6KB
- 0001161697-24-000162.txt ( ) — 1865KB
From the Filing
DEF 14A 1 schedule_14a.htm SCHEDULE 14A DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [X] Definitive Proxy Statement [ ] Definitive Additional Materials [ ] Soliciting Material under §240.14a-12 KORU Medical Systems, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): [X] No fee required. [ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities to which transaction applies: (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): (4) Proposed maximum aggregate value of transaction: (5) Total fee paid: [ ] Fee paid previously with preliminary materials. [ ] Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. (1) Amount Previously Paid: (2) Form, Schedule or Registration Statement No.: (3) Filing Party: (4) Date Filed: KORU Medical Systems, Inc. 100 Corporate Drive Mahwah, NJ 07430 800-624-9600 Notice of Annual Meeting of Shareholders to be held on May 9, 2024 The 2024 Annual Meeting of Shareholders (the “Annual Meeting”) of KORU Medical Systems, Inc. (the “Company”) will be held on May 9, 2024 at 8:00 a.m. Eastern Time at the Company’s offices at 100 Corporate Drive, Mahwah, NJ 07495. The Annual Meeting is to vote on the following matters: 1. Election of directors 2. Advisory approval of the compensation of the Company’s executive officers 3. Ratification of the appointment of independent registered public accountants 4. Approval of the 2024 Omnibus Equity Incentive Plan 5. Transaction of any other business that may properly come before the meeting The Company will also transact any other business that may properly come before the meeting. All shareholders are invited to attend the Annual Meeting. Only those shareholders of record at the close of business on March 11, 2024 are entitled to notice of and to vote at the Annual Meeting and any postponements or adjournments thereof. A complete list of shareholders entitled to vote at the Annual Meeting will be available for inspection by any shareholder at the Annual Meeting and during normal business hours at the Company’s corporate headquarters during the 10-day period immediately prior to the date of the Annual Meeting. Officers of the Company will be present at the Annual Meeting and available to respond to questions from shareholders. YOUR VOTE IS IMPORTANT. Whether or not you plan to attend the Annual Meeting, we urge you to vote and submit your proxy in advance of the meeting by one of the methods described in the proxy materials for the Annual Meeting. Shareholders who attend the Annual Meeting may revoke any previously submitted proxies and vote in person, by internet or by mobile device up until the polls close during the Annual Meeting. How to Vote: Mail Internet Mobile Device Sign, complete and return the proxy card in the postage paid envelope provided www.cstproxy.com - have your proxy card available when logging in Scan this QR code: Important Notice Regarding the Availability of Proxy Materials for the Meeting to be Held on May 9, 2024: This Proxy Statement, along with our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 is available at https://www.cstproxy.com/KORUMEDICAL/2024. By order of the Board of Directors, Thomas Adams Chief Financial Officer, Treasurer and Corporate Secretary KORU Medical Systems, Inc. 100 Corporate Drive Mahwah, NJ 07430 800-624-9600 Proxy Statement This Proxy Statement is furnished in connection with the solicitation of proxies by the Board of Directors of KORU Medical Systems, Inc. (the “Company” or “KORU Medical” and, as the context requires, “we”, “us” or “our”) to be used at the Company’s 2024 Annual Meeting of Shareholders to be held on May 9, 2024 at the time and place and for the purposes set forth in the accompanying Notice of Annual Meeting of Shareholders, and at any postpon